NASDAQ:AGIO

Agios Pharmaceuticals Stock Insider Trading

etoro logo Buy AGIO
*Your capital is at risk
$27.68
+1.17 (+4.41%)
At Close: Jun 03, 2026

Agios Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 4.64. In total, the insiders bought 987.62K and sold 86.14K AGIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
4.64
Buy 987.62K shares
Sell 86.14K shares
70% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Mar 02, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 02, 2026
Buy
Performance share units
M-Exempt
Gheuens Sarah
Chief Medical Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Buy
Common stock
M-Exempt
Jones Cecilia
Chief Financial Officer
C-Suite Officer 8 500
Value: $299.2K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Jones Cecilia
Chief Financial Officer
C-Suite Officer 8 500
Value: $299.2K
Apr 02, 2026
Buy
Common stock
M-Exempt
Milanova Tsveta
Chief Commercial Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Sell
Common stock
S-Sale
Milanova Tsveta
Chief Commercial Officer
Officer 3 262
Value: $113.2K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Milanova Tsveta
Chief Commercial Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Sell
Common stock
S-Sale
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 2 959
Value: $102.7K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 8 100
Value: $285.1K
Apr 02, 2026
Buy
Common stock
M-Exempt
Goff Brian
Chief Executive Officer
CEO / President 13 500
Value: $475.2K
Apr 02, 2026
Buy
Common stock
M-Exempt
Goff Brian
Chief Executive Officer
CEO / President 25 528
Value: $898.6K
Apr 02, 2026
Sell
Common stock
S-Sale
Goff Brian
Chief Executive Officer
CEO / President 12 472
Value: $432.9K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Goff Brian
Chief Executive Officer
CEO / President 13 500
Value: $475.2K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Goff Brian
Chief Executive Officer
CEO / President 25 528
Value: $898.6K
Apr 02, 2026
Buy
Performance share units
M-Exempt
Burns James William
Chief Legal Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Buy
Common stock
M-Exempt
Gheuens Sarah
Chief Medical Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Sell
Common stock
S-Sale
Gheuens Sarah
Chief Medical Officer
Officer 2 940
Value: $102.0K
Apr 02, 2026
Sell
Common stock
S-Sale
Burns James William
Chief Legal Officer
Officer 3 280
Value: $113.8K
Apr 02, 2026
Buy
Common stock
M-Exempt
Burns James William
Chief Legal Officer
Officer 8 500
Value: $299.2K
Apr 02, 2026
Sell
Common stock
S-Sale
Goff Brian
Chief Executive Officer
CEO / President 6 596
Value: $228.9K
Apr 02, 2026
Buy
Common stock
M-Exempt
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 8 100
Value: $285.1K
Apr 02, 2026
Sell
Common stock
S-Sale
Jones Cecilia
Chief Financial Officer
C-Suite Officer 3 141
Value: $109.0K
Mar 05, 2026
Buy
Common stock
M-Exempt
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 8 100
Value: $224.2K
Mar 05, 2026
Buy
Restricted stock units
M-Exempt
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 8 100
Value: $224.2K
Mar 05, 2026
Sell
Common stock
S-Sale
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Officer 2 959
Value: $82.3K
Mar 03, 2026
Sell
Common stock
S-Sale
Washburn Theodore James Jr.
Principal Accounting Officer
Officer 5 272
Value: $152.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE